The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
The global Sevelamer market was valued at US$ 220 million in 2023 and is anticipated to reach US$ 337.1 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Sevelamer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sevelamer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sevelamer include Sanofi, Impax Laboratories, InvaGen Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma and Amneal Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sevelamer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevelamer.
Report Scope
The Sevelamer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sevelamer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevelamer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Impax Laboratories
InvaGen Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Amneal Pharmaceuticals
Segment by Type
Tablet
Oral Suspension
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sevelamer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sevelamer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
The global Sevelamer market was valued at US$ 220 million in 2023 and is anticipated to reach US$ 337.1 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Sevelamer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sevelamer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sevelamer include Sanofi, Impax Laboratories, InvaGen Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma and Amneal Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sevelamer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevelamer.
Report Scope
The Sevelamer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sevelamer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevelamer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Impax Laboratories
InvaGen Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Amneal Pharmaceuticals
Segment by Type
Tablet
Oral Suspension
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sevelamer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sevelamer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sevelamer Market Overview
1.1 Product Overview and Scope of Sevelamer
1.2 Sevelamer Segment by Type
1.2.1 Global Sevelamer Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Sevelamer Segment by Application
1.3.1 Global Sevelamer Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Sevelamer Market Size Estimates and Forecasts
1.4.1 Global Sevelamer Revenue 2019-2030
1.4.2 Global Sevelamer Sales 2019-2030
1.4.3 Global Sevelamer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sevelamer Market Competition by Manufacturers
2.1 Global Sevelamer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sevelamer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sevelamer Average Price by Manufacturers (2019-2024)
2.4 Global Sevelamer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sevelamer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sevelamer, Product Type & Application
2.7 Sevelamer Market Competitive Situation and Trends
2.7.1 Sevelamer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sevelamer Players Market Share by Revenue
2.7.3 Global Sevelamer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sevelamer Retrospective Market Scenario by Region
3.1 Global Sevelamer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sevelamer Global Sevelamer Sales by Region: 2019-2030
3.2.1 Global Sevelamer Sales by Region: 2019-2024
3.2.2 Global Sevelamer Sales by Region: 2025-2030
3.3 Global Sevelamer Global Sevelamer Revenue by Region: 2019-2030
3.3.1 Global Sevelamer Revenue by Region: 2019-2024
3.3.2 Global Sevelamer Revenue by Region: 2025-2030
3.4 North America Sevelamer Market Facts & Figures by Country
3.4.1 North America Sevelamer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sevelamer Sales by Country (2019-2030)
3.4.3 North America Sevelamer Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sevelamer Market Facts & Figures by Country
3.5.1 Europe Sevelamer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sevelamer Sales by Country (2019-2030)
3.5.3 Europe Sevelamer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sevelamer Market Facts & Figures by Country
3.6.1 Asia Pacific Sevelamer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sevelamer Sales by Country (2019-2030)
3.6.3 Asia Pacific Sevelamer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sevelamer Market Facts & Figures by Country
3.7.1 Latin America Sevelamer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sevelamer Sales by Country (2019-2030)
3.7.3 Latin America Sevelamer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sevelamer Market Facts & Figures by Country
3.8.1 Middle East and Africa Sevelamer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sevelamer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sevelamer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sevelamer Sales by Type (2019-2030)
4.1.1 Global Sevelamer Sales by Type (2019-2024)
4.1.2 Global Sevelamer Sales by Type (2025-2030)
4.1.3 Global Sevelamer Sales Market Share by Type (2019-2030)
4.2 Global Sevelamer Revenue by Type (2019-2030)
4.2.1 Global Sevelamer Revenue by Type (2019-2024)
4.2.2 Global Sevelamer Revenue by Type (2025-2030)
4.2.3 Global Sevelamer Revenue Market Share by Type (2019-2030)
4.3 Global Sevelamer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sevelamer Sales by Application (2019-2030)
5.1.1 Global Sevelamer Sales by Application (2019-2024)
5.1.2 Global Sevelamer Sales by Application (2025-2030)
5.1.3 Global Sevelamer Sales Market Share by Application (2019-2030)
5.2 Global Sevelamer Revenue by Application (2019-2030)
5.2.1 Global Sevelamer Revenue by Application (2019-2024)
5.2.2 Global Sevelamer Revenue by Application (2025-2030)
5.2.3 Global Sevelamer Revenue Market Share by Application (2019-2030)
5.3 Global Sevelamer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Sevelamer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Sevelamer Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Impax Laboratories
6.2.1 Impax Laboratories Corporation Information
6.2.2 Impax Laboratories Description and Business Overview
6.2.3 Impax Laboratories Sevelamer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Impax Laboratories Sevelamer Product Portfolio
6.2.5 Impax Laboratories Recent Developments/Updates
6.3 InvaGen Pharmaceuticals
6.3.1 InvaGen Pharmaceuticals Corporation Information
6.3.2 InvaGen Pharmaceuticals Description and Business Overview
6.3.3 InvaGen Pharmaceuticals Sevelamer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 InvaGen Pharmaceuticals Sevelamer Product Portfolio
6.3.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.4 Dr. Reddy's Laboratories
6.4.1 Dr. Reddy's Laboratories Corporation Information
6.4.2 Dr. Reddy's Laboratories Description and Business Overview
6.4.3 Dr. Reddy's Laboratories Sevelamer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy's Laboratories Sevelamer Product Portfolio
6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Sevelamer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Sevelamer Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Amneal Pharmaceuticals
6.6.1 Amneal Pharmaceuticals Corporation Information
6.6.2 Amneal Pharmaceuticals Description and Business Overview
6.6.3 Amneal Pharmaceuticals Sevelamer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amneal Pharmaceuticals Sevelamer Product Portfolio
6.6.5 Amneal Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sevelamer Industry Chain Analysis
7.2 Sevelamer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sevelamer Production Mode & Process
7.4 Sevelamer Sales and Marketing
7.4.1 Sevelamer Sales Channels
7.4.2 Sevelamer Distributors
7.5 Sevelamer Customers
8 Sevelamer Market Dynamics
8.1 Sevelamer Industry Trends
8.2 Sevelamer Market Drivers
8.3 Sevelamer Market Challenges
8.4 Sevelamer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
